The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for ...

Health officials on Friday issued a fresh plea for Londoners to get vaccinated ahead of an expected surge of flu, Covid and ...

US pharma major GSK yesterday announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant ...

A new study shows otherwise healthy adults who take broad-spectrum antibiotics to treat community-acquired pneumonia are more likely to suffer adverse drug events. Also in the news: evolution of covid ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

The Centers for Disease Control and Prevention and the New Orleans Health Department encourage residents to vaccine against ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

GSK (GSK) announced new preliminary data for AREXVY in adults aged 18-49 at increased risk for lower respiratory tract disease, LRTD, caused by ...

The Centers for Disease Control and Prevention is urging some people to get additional doses of the COVID-19 vaccine for ...

Arexvy is currently approved for active immunization for the prevention of LRTD caused by RSV in individuals 60 years of age and older, and those 50 to 59 years of age who are at increased risk for ...

GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for ...

Important information new parents need to know about Respiratory Syncytial Virus, or RSV. It comes around when the weather ...